Boston Scientific (BSX) has issued an update.
Boston Scientific Corporation has expanded its Board of Directors by appointing Dr. Cheryl Pegus, who will serve until the next annual stockholders’ meeting. Dr. Pegus will join the Executive Compensation and Human Resources Committee and the Risk Committee, receiving a prorated standard compensation package for non-employee directors. In addition, the company has updated its By-Laws for clerical and administrative purposes and extended its $2.750 billion credit agreement’s maturity date, adjusting the terms related to the Maximum Leverage Ratio covenant.
See more insights into BSX stock on TipRanks’ Stock Analysis page.
